As of 2025-07-04, the Intrinsic Value of Mesa Laboratories Inc (MLAB) is 112.42 USD. This MLAB valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 100.63 USD, the upside of Mesa Laboratories Inc is 11.70%.
The range of the Intrinsic Value is 50.32 - 779.77 USD
Based on its market price of 100.63 USD and our intrinsic valuation, Mesa Laboratories Inc (MLAB) is undervalued by 11.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 50.32 - 779.77 | 112.42 | 11.7% |
| DCF (Growth 10y) | 82.57 - 1,095.46 | 169.33 | 68.3% |
| DCF (EBITDA 5y) | 97.90 - 134.80 | 112.58 | 11.9% |
| DCF (EBITDA 10y) | 131.51 - 209.77 | 163.25 | 62.2% |
| Fair Value | -1.82 - -1.82 | -1.82 | -101.81% |
| P/E | (9.80) - 57.00 | 19.86 | -80.3% |
| EV/EBITDA | 94.30 - 177.19 | 131.16 | 30.3% |
| EPV | 55.31 - 112.95 | 84.13 | -16.4% |
| DDM - Stable | (3.83) - (22.05) | (12.94) | -112.9% |
| DDM - Multi | 41.35 - 192.43 | 68.91 | -31.5% |
| Market Cap (mil) | 546.42 |
| Beta | 1.23 |
| Outstanding shares (mil) | 5.43 |
| Enterprise Value (mil) | 697.05 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.06% |
| Cost of Debt | 8.19% |
| WACC | 7.55% |